CONMED Corp — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-06-01

Reporting Person: BRONSON DAVID M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-01	Common Stock	M	335	—	Acquired	15110	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-01	Rsus (restricted Stock Units)	$0	M	335	Disposed	2032-06-01	Common Stock (335)	Direct
2023-06-01	Rsus (restricted Stock Units)	$0	A	302	Acquired	2033-06-01	Common Stock (302)	Direct
2023-06-01	Options To Purchase Common Stock	$123.79	A	2826	Acquired	2033-06-01	Common Stock (2826)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

F2: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.